Cargando…
Molecular mechanisms of tumor resistance to radiotherapy
BACKGROUND: Cancer is the most prevalent cause of death globally, and radiotherapy is considered the standard of care for most solid tumors, including lung, breast, esophageal, and colorectal cancers and glioblastoma. Resistance to radiation can lead to local treatment failure and even cancer recurr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268375/ https://www.ncbi.nlm.nih.gov/pubmed/37322433 http://dx.doi.org/10.1186/s12943-023-01801-2 |
_version_ | 1785059079223246848 |
---|---|
author | Wu, Yu Song, Yingqiu Wang, Runze Wang, Tianlu |
author_facet | Wu, Yu Song, Yingqiu Wang, Runze Wang, Tianlu |
author_sort | Wu, Yu |
collection | PubMed |
description | BACKGROUND: Cancer is the most prevalent cause of death globally, and radiotherapy is considered the standard of care for most solid tumors, including lung, breast, esophageal, and colorectal cancers and glioblastoma. Resistance to radiation can lead to local treatment failure and even cancer recurrence. MAIN BODY: In this review, we have extensively discussed several crucial aspects that cause resistance of cancer to radiation therapy, including radiation-induced DNA damage repair, cell cycle arrest, apoptosis escape, abundance of cancer stem cells, modification of cancer cells and their microenvironment, presence of exosomal and non-coding RNA, metabolic reprogramming, and ferroptosis. We aim to focus on the molecular mechanisms of cancer radiotherapy resistance in relation to these aspects and to discuss possible targets to improve treatment outcomes. CONCLUSIONS: Studying the molecular mechanisms responsible for radiotherapy resistance and its interactions with the tumor environment will help improve cancer responses to radiotherapy. Our review provides a foundation to identify and overcome the obstacles to effective radiotherapy. |
format | Online Article Text |
id | pubmed-10268375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102683752023-06-15 Molecular mechanisms of tumor resistance to radiotherapy Wu, Yu Song, Yingqiu Wang, Runze Wang, Tianlu Mol Cancer Review BACKGROUND: Cancer is the most prevalent cause of death globally, and radiotherapy is considered the standard of care for most solid tumors, including lung, breast, esophageal, and colorectal cancers and glioblastoma. Resistance to radiation can lead to local treatment failure and even cancer recurrence. MAIN BODY: In this review, we have extensively discussed several crucial aspects that cause resistance of cancer to radiation therapy, including radiation-induced DNA damage repair, cell cycle arrest, apoptosis escape, abundance of cancer stem cells, modification of cancer cells and their microenvironment, presence of exosomal and non-coding RNA, metabolic reprogramming, and ferroptosis. We aim to focus on the molecular mechanisms of cancer radiotherapy resistance in relation to these aspects and to discuss possible targets to improve treatment outcomes. CONCLUSIONS: Studying the molecular mechanisms responsible for radiotherapy resistance and its interactions with the tumor environment will help improve cancer responses to radiotherapy. Our review provides a foundation to identify and overcome the obstacles to effective radiotherapy. BioMed Central 2023-06-15 /pmc/articles/PMC10268375/ /pubmed/37322433 http://dx.doi.org/10.1186/s12943-023-01801-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Wu, Yu Song, Yingqiu Wang, Runze Wang, Tianlu Molecular mechanisms of tumor resistance to radiotherapy |
title | Molecular mechanisms of tumor resistance to radiotherapy |
title_full | Molecular mechanisms of tumor resistance to radiotherapy |
title_fullStr | Molecular mechanisms of tumor resistance to radiotherapy |
title_full_unstemmed | Molecular mechanisms of tumor resistance to radiotherapy |
title_short | Molecular mechanisms of tumor resistance to radiotherapy |
title_sort | molecular mechanisms of tumor resistance to radiotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268375/ https://www.ncbi.nlm.nih.gov/pubmed/37322433 http://dx.doi.org/10.1186/s12943-023-01801-2 |
work_keys_str_mv | AT wuyu molecularmechanismsoftumorresistancetoradiotherapy AT songyingqiu molecularmechanismsoftumorresistancetoradiotherapy AT wangrunze molecularmechanismsoftumorresistancetoradiotherapy AT wangtianlu molecularmechanismsoftumorresistancetoradiotherapy |